Health groups prepare for the unthinkable: Working with RFK Jr.
As Robert F. Kennedy Jr. faces Senate confirmation hearings Wednesday and Thursday, health advocates find themselves in an ...
5 key health topics to watch at RFK Jr.'s Senate confirmation hearings
Robert F. Kennedy Jr. is set to appear before the Senate Finance Committee for the first of two confirmation hearings as ...
clinicaladvisor.com3h
Trump Administration Puts Freeze on Release of Health Info From Government Agencies
President Donald Trump’s administration has placed a freeze on information being released from government health agencies. According to a memo obtained by the Associated Press, the “immediate pause” ...
northcarolinahealthnews.org8h
New Trump directive to federal health & research agencies could hit NC in the pocketbook
President Trump issued a directive temporarily halting communications, meetings and purchases related to federal health care ...
Researchers studying whether medical cannabis could help late-stage dementia patients
As research continues, those involved say this would be a game changer, especially for patients with very limited options.
Hosted on MSN18h
Food-Related Topics RFK Jr. Will Present at Senate Confirmation Hearing
Robert F. Kennedy Jr. will appear as President Donald Trump's nominee for Secretary of the Department of Health and Human ...
Halt to federal health communications raise concerns for bird flu response
The Trump administration has paused public communications from health agencies, causing concern for California's ability to ...
Editorial: Not all ‘processed’ food is bad — but Red Dye No. 3 and harmful chemicals don’t belong in what we eat
Jim Richards doesn’t look like a mad scientist and his plant-based milk made from macadamia nuts tastes delicious. Yet his ...
BioArctic: FDA approves IV maintenance dosing of Leqembi (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US
BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's ...
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
INDICATION LEQEMBI ® [ (lecanemab-irmb) 100 mg/mL injection for intravenous use] is indicated for the treatment of Alzheimer’s disease (AD). Treatment with LEQEMBI should be initiated in patients with ...